Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_assertion description "[For defined tumor types, expression of at least one of the SSX family members was most frequently observed in head and neck cancer (75%), followed by ovarian cancer (50%), malignant melanoma (43%), lymphoma (36%), colorectal cancer (27%) and breast cancer (23%), while leukemias and the few cases of leiomyosarcomas, seminomas and thyroid cancers were found not to express any SSX gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_assertion evidence source_evidence_literature NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_assertion SIO_000772 9639388 NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_assertion wasDerivedFrom befree-2016 NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_assertion wasGeneratedBy ECO_0000203 NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1397989.RAxigitM-5vnFLeMnrXqK1d81RSFOS1yc-MW2Ho-HgytQ130_provenance.